Effectiveness of simeprevir-based triple therapy for patients with telaprevir failure
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000016205
- Lead Sponsor
- The Kyushu Univerisity Liver Disease Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen 2. Clinical or biochemical evidence of hepatic decompensation (Child-Pugh B or C, ascites, bleeding varices, or encephalopathy); 3. Other causes of liver disease (hemochromatosis, autoimmune hepatitis, or primary biliary cirrhosis) 4. Excessive active alcohol consumption (a daily intake of more than 40g of ethanol), drug abuse or severe mental disorder 5. The presence of active cancer at entry
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method